Skiplink Navigation

Main Features

Novartis increases Q3 profit

Novartis earned $2.08 billion (SFr2.36 billion) on $10.75 billion in sales in the third quarter of 2008, the pharmaceutical giant said on Monday.

The result, a 12 per cent increase over the same period last year, brings the Basel-based firm's net sales to $31.38 billion and net income to $6.66 billion for the first nine months of the year.

The Swiss drugmaker had benefited from positive currency translation and in particular, from a weak United States dollar.

The group's operating income advanced 24 per cent to $7.28 billion up to September, which the firm credited to an efficiency initiative focusing on innovation and expanding high-growth markets.

Novartis also said it would be cutting 550 jobs in the US, following in the steps of rivals Pfizer, GlaxoSmithKline and France's Sanofi-Aventis.

On Friday, the firm also said it had appointed Joerg Reinhardt as it's chief operating officer and that the head of its consumer health unit, Thomas Ebeling, was leaving the company.


Neuer Inhalt

Horizontal Line

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!